Aurobindo Pharma

Aurobindo Pharma Limited (NSE: AUROPHARMA; BSE: 524804) is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, New Jersey. Aurobindo develops, manufactures, and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs) across oral solids, injectables, and over-the-counter products, with manufacturing operations in India, the U.S., Brazil, and Portugal. The company is one of the largest generic-ARV (antiretroviral) suppliers globally and is expanding into biosimilars, vaccines, and peptides through its biologics division.